ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05340	Primary immunodeficiency	6/51	30/7206	4.84396085306e-08
ko04060	Cytokine-cytokine receptor interaction	10/51	191/7206	6.71832646308e-07
ko05145	Toxoplasmosis	7/51	126/7206	2.58387843693e-05
ko05152	Tuberculosis	8/51	187/7206	4.33556494763e-05
ko04145	Phagosome	7/51	162/7206	0.000128437750714
ko05140	Leishmaniasis	5/51	75/7206	0.000172658636554
ko04660	T cell receptor signaling pathway	6/51	124/7206	0.000219845802392
ko05144	Malaria	4/51	45/7206	0.000267750405643
ko05416	Viral myocarditis	4/51	55/7206	0.000581788461368
ko05330	Allograft rejection	3/51	24/7206	0.000608769327487
ko05321	Inflammatory bowel disease (IBD)	4/51	56/7206	0.000623289075897
ko04620	Toll-like receptor signaling pathway	5/51	100/7206	0.000659390781078
ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	3/51	28/7206	0.000965888987732
ko05320	Autoimmune thyroid disease	3/51	29/7206	0.00107198428884
ko04612	Antigen processing and presentation	4/51	77/7206	0.00205904597512
ko04514	Cell adhesion molecules (CAMs)	5/51	130/7206	0.00213783990673
ko04630	Jak-STAT signaling pathway	5/51	132/7206	0.00228580285801
ko04670	Leukocyte transendothelial migration	5/51	151/7206	0.00408832493354
ko04650	Natural killer cell mediated cytotoxicity	4/51	97/7206	0.00475270371329
ko04621	NOD-like receptor signaling pathway	5/51	157/7206	0.00482480785003
ko05310	Asthma	2/51	17/7206	0.00624081517654
ko04659	Th17 cell differentiation	4/51	106/7206	0.00650417658467
ko04217	Necroptosis	5/51	178/7206	0.00814994133326
ko04210	Apoptosis	5/51	180/7206	0.00853299638095
ko05134	Legionellosis	3/51	74/7206	0.0152179088176
ko05166	HTLV-I infection	6/51	292/7206	0.0163531051626
ko05133	Pertussis	3/51	87/7206	0.0233426805784
ko04672	Intestinal immune network for IgA production	2/51	37/7206	0.027935812519
ko04658	Th1 and Th2 cell differentiation	3/51	96/7206	0.0301079153488
ko04064	NF-kappa B signaling pathway	3/51	96/7206	0.0301079153488
ko05161	Hepatitis B	4/51	173/7206	0.0334336176291